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Rumen protected Methionine (MET) and Lysine (LYS) are critical for milk protein 
synthesis in dairy cows. N-acetyl-L-methionine (NALM) is a MET derivative that 
consists of L-Met protected with an acetyl group that is attached to the α-amino group. 
N-acetyl-L-lysine (NALL) is a LYS derivative that is similarly protected. The objectives 
of these studies were to quantify the gastrointestinal availability of NALM and NALL. 
Three experiments were run as 3 × 3 Latin square using 3 second lactation Holstein cows 
that have been fitted with cannulas in the rumen and duodenum. The cows were fed diets 
containing the supplements for two weeks prior to each experiment so that the rumen 
microbes had time to adjust to the supplement. Each period consisted of 10 d of 
adaptation followed by 2 d of sampling. A dose of 0, 30, or 60 g of NALM was placed 





were similarly supplied with 0, 60, or 120 g of ƐNALL during experiment 2. The cows 
were supplemented with 0 g, 120 g of ƐNALL, or 120 g of diNALL during experiment 
3. On day one of sampling, a liquid marker (Co-EDTA) was also administered at the 
time of the protected AA administration. Blood, ruminal, and duodenal samples were 
taken at hours 0, 1, 3, 6, 9, 12, and 24 post-feeding. There were no differences for milk 
production, milk protein, milk fat, or DMI for NALM or either NALL. There were no 
differences for ruminal escape (69.1% and 46.2% respectively) and duodenal appearance 
(2.16% and 3.40% respectively). The ruminal escape of ƐNALL was not different 
between the 120 g dose (32.7%) and the 60 g dose (27.2%). Duodenal appearance was 
higher (P < 0.01) for the 60 g dose (2.86%) than for the 120 g dose (1.19%) of ƐNALL. 
Acetate, propionate, butyrate, and valerate were higher (P < 0.01) for the supplemented 
cows during experiment 1 with NALL. There were no differences between ƐNALL and 
diNALL for rumen escape, duodenal appearance, VFA production, or blood LYS AUC. 
Results of the experiment verify significant protection of the N-acetyl MET and LYS 
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Rumen protected Methionine (MET) and Lysine (LYS) are critical for milk protein 
synthesis in dairy cows. N-acetyl-L-methionine (NALM) is a MET derivative that 
consists of L-Met protected with an acetyl group that is attached to the α-amino group. 
N-acetyl-L-lysine (NALL) is a LYS derivative that is similarly protected. The objectives 
of these studies were to quantify the gastrointestinal availability of NALM and NALL. 
Three experiments were run as 3 × 3 Latin square using 3 second lactation Holstein cows 
that have been fitted with cannulas in the rumen and duodenum. The cows were fed diets 
containing the supplements for two weeks prior to each experiment so that the rumen 
microbes had time to adjust to the supplement. Each period consisted of 10 d of 
adaptation followed by 2 d of sampling. A dose of 0, 30, or 60 g of NALM was placed 
under the rumen mat at the time of feeding every day during experiment 1. The cows 
were similarly supplied with 0, 60, or 120 g of ƐNALL during experiment 2. The cows 
were supplemented with 0 g, 120 g of ƐNALL, or 120 g of diNALL during experiment 
3. On day one of sampling, a liquid marker (Co-EDTA) was also administered at the 
time of the protected AA administration. Blood, ruminal, and duodenal samples were 





production, milk protein, milk fat, or DMI for NALM or either NALL. There were no 
differences for ruminal escape (69.1% and 46.2% respectively) and duodenal appearance 
(2.16% and 3.40% respectively). The ruminal escape of ƐNALL was not different 
between the 120 g dose (32.7%) and the 60 g dose (27.2%). Duodenal appearance was 
higher (P < 0.01) for the 60 g dose (2.86%) than for the 120 g dose (1.19%) of ƐNALL. 
Acetate, propionate, butyrate, and valerate were higher (P < 0.01) for the supplemented 
cows during experiment 1 with NALL. There were no differences between ƐNALL and 
diNALL for rumen escape, duodenal appearance, VFA production, or blood LYS AUC. 
Results of the experiment verify significant protection of the N-acetyl MET and LYS 







I am incredibly grateful to be here today. I know that there is no way that I could have 
reached this point without the help of many people. First of all, I would like to thank the 
many workers in the USU nutrition lab. The many hours that you spent helping me feed 
cows and take samples is greatly appreciated. I am especially thankful for the help of Dr. 
Yang, Cody, and Anisa. The time you spent on the farm and in the lab was invaluable to 
the completion of my project. I would also like to thank the many workers of the Caine 
Dairy Research Center. The time that all of you spent taking milk samples was essential 
to the success of my project. I would also like to thank Dr. Rusty Stott. I could not have 
been successful if it had not been for your time and energy. Thank you for helping to 
monitor the health of the research cows. 
I would like to thank the members of my committee for taking the time necessary to 
work with me. Dr. Rood, I appreciate that you were willing to support me in my goal to 
get a master’s degree. Thank you for coming to meetings and beings willing to revise my 
writings. I am grateful to Dr. Eun for helping me get where I am today. It was in your 
class as an undergraduate that my interest in nutrition was first piqued.  I am glad that 
you had enough faith in me to take me on as a graduate student. I am grateful for the 
opportunities that I had to work on your research projects as an undergraduate student. 
Thank you for guiding me as I began my journey in this program. 
 
I would also like to thank Dr. Hall. I know that you do not have much time to spare. 
 
I appreciate that you spent so much of it on me. I am grateful that you were willing to 





you spent teaching the class on vitamins and minerals. That class helped me to learn a lot 
that I had not previously known. I also am grateful for how much you have helped me 
increase my desire to understand new concepts in greater depth.  I am amazed at how 
well you balance knowledge with your ability to teach at the level of your students. 
Thank you for making time to accept me as your student. I would not have been able to 
complete my degree without your support. 
Finally, I would be remiss if I did not thank my family. Dad, since I was a little girl, 
you have instilled in me a desire to learn. Thank you for supporting me in my college 
career. Mom, you have always been my rock. With your help and encouragement, I had 
the courage to pursue my degree. I cannot thank you enough for the times you have 
helped me study throughout my years here at Utah State University. Of course, I never 
would have made it this far without the love and support of my husband, Kevin. Thank 
you for understanding that my work and my school required so much time. Thank you 










COPYRIGHT ..................................................................................................................... ii 
ABSTRACT ...................................................................................................................... iii 
PUBLIC ABSTRACT ........................................................................................................ v 
ACKNOWLEDGMENTS .............................................................................................. vii 
LIST OF TABLES ............................................................................................................. xi 
LIST OF ABBREVIATIONS ......................................................................................... xiii 
CHAPTER 
I. INTRODUCTION ............................................................................................ 1 
II. REVIEW OF LITERATURE ........................................................................... 3 
Protein… ........................................................................................................... 3 
Crude Protein… ................................................................................................ 5 
Microbial Protein Synthesis .............................................................................. 6 
Synchronization… ............................................................................................ 6 
Fate of Protein… ............................................................................................... 7 
Liver ....................................................................................................... 7 
Mammary Gland .................................................................................... 7 
Nitrogen Recycling ........................................................................................... 8 
Amino Acids ..................................................................................................... 8 
Methionine ...................................................................................................... 11 
Coating Technology ............................................................................. 11 
D,L Isomers .......................................................................................... 13 
HMB ..................................................................................................... 13 
HMBi ................................................................................................... 14 
Smartamine .......................................................................................... 15 
NALM ...................................................................................................... 16 
Liver Metabolism ................................................................................. 16 
Utilization ............................................................................................. 17 
x 
 
DMI ...................................................................................................... 18 
Milk ...................................................................................................... 18 
Immunity .............................................................................................. 19 
Lysine .............................................................................................................. 19 
Coating ................................................................................................. 20 
Forms and Availability ......................................................................... 21 
Lactation ............................................................................................... 22 
DMI ...................................................................................................... 22 
Cobalt as a Marker ........................................................................................... 23 
Conclusion… .................................................................................................. 23 
III. METHIONINE ............................................................................................... 25 
Introduction… ................................................................................................. 27 
Materials and Methods .................................................................................... 29 
Animals and Diets ................................................................................ 29 
Sampling .............................................................................................. 30 
Chemical Analysis ............................................................................... 32 
Calculations and Statistical Analysis ................................................... 33 
Results and Discussion ................................................................................... 34 
IV. LYSINE .......................................................................................................... 38 
Introduction… ................................................................................................. 40 
Materials and Methods .................................................................................... 42 
Animals and Diets ................................................................................ 42 
Sampling .............................................................................................. 43 
Chemical Analysis ............................................................................... 44 
Calculations and Statistical Analysis… ............................................... 46 
Results and Discussion ................................................................................... 48 
V. CONCLUSION .............................................................................................. 56 











1 Ingredients and chemical composition of the experimental diets with varying  
does of N-acetyl-L-methionine and metasmart supplemented to early lactation 
Holstein dairy cows ............................................................................................... 30 
 
2 Dry matter intake, body weight, and milk parameters of second lactation dairy 
cows fed rumen protected methionine .................................................................. 34 
 
3 Ruminal pH, ammonia-N, volatile fatty acid profiles, and blood methionine 
concentration of second lactation dairy cows fed a diet with rumen-protected 
methionine..............................................................................................................35 
 
4 Ruminal escape and duodenal appearance NALM in second lactation dairy  




1 Ingredients and chemical composition of the experimental diets with varying  
does of N-acetyl-L-lysine supplemented to early lactation Holstein dairy cows . 43 
 
 
2 Dry matter intake, body weight, and milk parameters of second lactation dairy 
cows fed rumen-protected lysine .......................................................................... 48 
 
3 Ruminal pH, ammonia-N, volatile fatty acid profiles, and blood lysine in  
                          second lactation dairy cows fed a diet with rumen-protected lysine .................... 50 
 
 
4 Ruminal escape and duodenal appearance NALL in second lactation dairy cows 
fed a diet with rumen-protected lysine ...................................................................51 
 
 
5 Dry matter intake, body weith, and milk parameters of second lactation dairy 





6 Ruminal pH, ammonia-N, volatile fatty acid profiles, and blood lysine in  
second lactation dairy cows fed a diet with rumen-protected lysine .................... 53 
7 Ruminal escape and duodenal appearance NALL in second lactation dairy cows 
fed a diet with rumen-protected lysine ...................................................................54 
xiii 
 
LIST OF ABBREVIATIONS 
 
AA = amino acid 
 
ADF = acid detergent fiber 
AUC = area under the curve 
BCS = body condition score 
BHBA = beta-hydroxybutyrate 
BUN = blood urea nitrogen 
BW = body weight 
CP = crude protein 
 
DNA = deoxyribonucleic acid 
DIM = days in milk 
diNALL = Nα,Ɛ-acetyl-L-Lysine 
DM = dry matter 
DMI = dry matter intake 
EAA = essential amino acid 
ECM = energy corrected milk 
ƐNALL = ƐN-acetyl-L-Lysine 
 
HMB = DL-2-hydroxy-4-(Methylthio)-butanoic acid 
 
HMBi = isopropyl ester of 2-hydroxy-4-(Methylthio)-butanoic acid 
LCFA = long chain fatty acid 
LYS = Lysine 





MPS = microbial protein synthesis 
MUN = milk urea nitrogen 
N = nitrogen 
 
NALL = N-acetyl-L-Lysine 
NALM = N-acetyl-L-Methionine 
NDF = neutral detergent fiber 
NH3-N = ammonia nitrogen 
NRC = national research council 
RNA = ribonucleic acid 
RDP = ruminally degradable protein 
RPAA = rumen protected amino acid 
RUP = ruminally undegradable protein 
TMR = total mixed rations 
VFA = volatile fatty acids 
 






Protein Metabolism is a complicated process in ruminants. Rumen microbes degrade much 
of the protein that is provided in the diet (Giallongo et al., 2016). This means that some protein 
is not available for systemic use by the animal. Dairy cows require protein to build enzymes and 
build tissue. Protein is also necessary for synthesis of milk proteins. Inadequate dietary protein 
makes it impossible for a cow to sustain high milk production (Lee et al., 2015). 
Proteins are built using different amino acids (AA). There are AA that cannot be adequately 
synthesized by the animal and must therefore be supplied in the diet. These are referred to as 
essential AA (EAA) (Schwab et al., 2010). The EAA that are not typically supplied in sufficient 
amounts in the diet are said to be limiting. The two most limiting AA in a typical dairy diet are 
Lysine (LYS) and Methionine (MET) (Weiss et al., 2002). Simply supplementing diets with 
free MET and LYS does not suffice due to the extensive degradation and use of these AA by 
rumen microbes (Chalupa et al., 1976. Onodera et al., 1993). 
Many methods have evolved over time to protected MET and LYS from rumen 
degradation. Some minerals were bound with AA to provide protection. This proved to be 
ineffective and costly (Graulet et al., 2005). Lipid coatings were fairly effective at ruminally 
protecting MET and LYS, but the amount of AA that was released in the small intestine was 
minimal at best (Schwab and Ordway, 2003; Sakkers et al., 2013). 
Protecting LYS has proven more difficult than for MET. Methods are frequently less 
effective for LYS (Rossi et al., 2003). For this reason, LYS is still most commonly protected 
with lipids. Less information is available for LYS than for MET on the effectiveness of 
different protection methods (Evans et al., 2015). 
2 
When studied by Rossi et al., (2003), ethyl-cellulose coating also released lower 
 
 
amounts of MET into the small intestine than had been expected. Various MET analogs 
and precursors have been used as well, but often have low bioavailability (Koenig et al., 
1999; Graulet et al., 2005). The protection method that appears to provide the most 
bioavailability so far appears to be the pH sensitive polymer (Schwab et al., 2010). 
N-acetyl-L-Methionine (NALM) and N-acetyl-L-Lysine (NALL) are both derivatives 
that are protected in the rumen by attaching an acetyl group to the α-amino group of the AA. 
The acetyl group protects the MET or LYS from microbial degradation by blocking 
aminopeptidase from accessing the amino group (Wallace et al., 1993). The acetyl group is 
then cleaved from the AA in the small intestine. The released AA should then become 
available for absorption (Baxter et al., 2001). The current studies were intended to 
determine the ruminal protection and intestinal availability of MET and LYS from NALM 





REVIEW OF LITERATURE 
 
In the United States, milk is sold under the multiple component pricing system. This means 
that milk fat, and milk protein are more valuable to dairy farmers than the liquid portion. Many 
methods have been tried in order to increase milk protein yield. Supplementation has thus far 
proven to be the most useful. Protein supplements, however, can be expensive and total protein 
costs can be up to 80% of feed costs. Therefore, efficient protein utilization is paramount to 
maintaining the health and high production of the modern dairy cow while also keeping costs as 
low as possible.  Increasing protein utilization in ruminants also decreases the amount of 
nitrogen that is lost into the environment via urine and manure. This has become more and more 
important as environmental concerns are receiving increasing attention. Rumen protected amino 
acids (RPAA) have been developed in order to supply the specific amino acids (AA) needed by 
the cow in the amounts necessary. Methionine (MET) and Lysine (LYS) are generally accepted 
as the most limiting AA when an alfalfa hay and corn silage diet is fed. For this reason, 
emphasis has been placed on successfully protecting these two AA from degradation in the 
rumen. This literature review will discuss some of the ways that MET and LYS have been 
protected, and the ramifications they have on production in dairy cattle. 
Protein 
 
Cattle have evolved to utilize diets that were low in digestible protein. The ability to take 
plant proteins, as well as other protein building blocks, and turn them into meat and milk is an 
advantageous characteristic of ruminants. Because of this, nitrogen efficiency may decrease as 
high protein feeds are fed. However, much research is still needed to fully understand the 
particulars of protein digestion and use in the ruminant digestive tract (Calsamiglia et al., 2010). 
4 
Protein utilization is an inefficient process in ruminants. Due to fermentation by rumen 
 
 
microbes, much of the protein that is supplied in the diet is not the protein that is available for the 
systemic use of the cow. Only 20-35% of dietary crude protein (CP) will be used in the 
production of milk proteins (Giallongo et al., 2016). Many strategies, such as low protein feeds, 
supplying limited energy, altering rumen degradable (RDP) and rumen undegradable protein 
(RUP) ratios, and protecting amino acids from rumen degradation have been employed to 
improve the efficiency of this process.  Although microbial fermentation efficiency has 
improved, little has been accomplished in overall nitrogen utilization efficiency over the last few 
decades (Calsamiglia et al., 2010). However, much has been learned about protein use in the 
dairy cow. After parturition, cows begin producing large quantities of milk, which requires a lot 
of nutrients. At the same time, dry matter intake (DMI) is low in the days following parturition. 
This results in a negative energy balance for cattle. This is especially true for high producing 
dairy cows. There is a high demand for high quality protein in the diet during early lactation in 
order to both maintain milk protein production and to reduce body weight (BW) loss. Protein 
that is consumed by the cow goes to the rumen where microbes break it down into ammonia and 
peptides. These are used by bacteria and protozoa for their own growth requirements and 
microbial protein synthesis. These microbes will eventually be washed out of the rumen and into 
the lower digestive tract. The cow is then able to digest these microbes in the abomasum and 
utilize their protein.  Most protein that is available to the cow post-ruminally comes in the form 
of microbial protein (NRC, 2001).  Generally, protein from bacteria and protozoa contains a 
good balance of AA. However, the proportions are not consistent. The small intestine also uses 
some AA before they can be absorbed into the blood stream (Calsamiglia et al., 2010). This 




bloodstream. Knowing the amount of each AA that is delivered to the cow is important because 
dairy cows can function on non-protein nitrogen, but high milk production is not sustainable 
without the proper balance of AA (Lee et al., 2015). 
Crude Protein 
 
Traditionally, diets were formulated based on concentration of CP. There are two main 
types of protein within CP. Those consist of protein that can be digested by the rumen microbes 
and that which passes through the rumen and may become available directly to the cow. RDP 
and RUP must be balanced in order to maintain rumen health and high production. Adequate 
RDP-about 10% DM-will be utilized for microbial growth as long as there is sufficient energy 
(Weiss et al., 2002). However, feeding an excess of RDP results in large amounts of nitrogen 
that cannot be fully utilized by rumen microbes (Weiss et al., 2002). This excess nitrogen is 
absorbed into the blood in the form of ammonia. The liver converts the ammonia into urea. The 
urea can then be excreted in the urine. Excess urea can build up in the blood and can reach toxic 
concentrations. A high concentration of BUN can lead to a decrease in reproductive efficiency 
(NRC, 2001). In order to decrease the negative effects that feeding excess CP has on the body 
and the environment, many researchers and farmers began putting deficient amounts of CP in the 
diet. This also proved to be problematic in terms of productivity.  In one study done by 
Giallongo et al. (2016), lowering the amount of CP in the diet caused DMI to decrease. A 
reduction in DMI can be costly for a dairy because it can negatively affect milk production and 
milk protein yield (Giallongo et al., 2016). This is due to the fact that, as previously discussed, 
microbes require RDP for growth. Furthermore, RUP is required to maintain high milk 
production because this supplies protein for absorption by the cow. In a study by Osorio et al. 




production in the following lactation. All of these benefits are lost if CP is lowered too far 
below dietary requirements, or if RDP and RUP are not provided in proper proportions. Current 
research shows that much more attention should be paid to the amount of AA in the diet rather 
than overall CP (Schwab, 2010). 
Microbial Protein Synthesis 
 
Microbial protein synthesis (MPS) is important because after the microbes die, they are 
digested by the cow. Increasing MPS increases the amount of microbial protein that flows into 
the abomasum and is utilized. It simultaneously decreases the amount of excess ammonia-N 
present in the rumen as microbes incorporate it into their proteins. Small peptides and AA 
supply an important source of nitrogen for microbes. In fact, these take less energy to utilize 
than complete proteins (Calsamiglia et al., 2010). The efficiency at which these molecules are 
used can be decreased by protozoa that ingest bacteria. Some of this nitrogen can be recovered 
by the cow when these microorganisms wash into the abomasum. However, some purines are 
not bioavailable, and will therefore be lost. The majority of microbial N is present in the form of 
amino acid-N. These can be broken down and used by the cow. Nucleic acid-N cannot be 
completely broken down and will be excreted in the urine. (Calsamiglia et al., 2010). 
Synchronization 
 
Nitrogen from protein cannot be fully utilized in the rumen unless adequate carbohydrates 
are also being fed. Carbohydrates supply the energy required by the rumen microbes to break 
down dietary protein and incorporate it into microbial protein (NRC, 2001). If there are not 
enough carbohydrates available, the cow must deal with the excess protein. This is costly to the 
animal. Energy is spent taking excess protein and converting it into urea so that it can excreted 




microbes in the rumen are able to break dietary protein down to ammonia and peptides. Excess 
ammonia is then absorbed through the rumen wall into the blood. From there it can be recycled 
or eliminated from the body (Wu et al., 2012). 
Fate of Protein 
Liver 
The AA that are available to the mammary gland are not present in the same amounts that 
they were absorbed. This is due to the fact that the liver utilizes some AA. It catabolizes many 
proteins and uses many AA for the carbon backbones during glucose synthesis (Calsamiglia et 
al., 2010). Methionine may be removed by the liver in large quantities. The liver may oxidize 
MET or use it to synthesize export proteins (Vyas et al., 2009). 
Mammary gland 
 
Nitrogen utilization in the mammary gland is a complex process. The extent to which AA 
are used can vary dramatically.  The more AA that are available in the bloodstream, the more 
that can be used for protein synthesis in the mammary gland. When there are less AA present, 
the body will increase overall blood flow (Calsamiglia et al., 2010). This increase in blood flow 
increases the AA that pass through the liver and may increase the AA available for use in the 
mammary gland. This is a process that is most effective during early lactation. The epithelial 
cells inside the mammary gland also have the ability to increase the percent of AA that are 
absorbed when the supply from the bloodstream is low and there are many proteins present in the 
mammary gland that 0 g dose the synthesis of proteins once the AA have been absorbed 






Nitrogen recycling is an advantageous characteristic of ruminants. Recycling refers to when 
nitrogen is brought back from the blood stream into the rumen, where it can be used by 
microbes. The use of this pathway theoretically increases with the decrease of available dietary 
nitrogen. Ammonia is absorbed from the rumen and transported to the liver. The ammonia is 
converted to urea. Urea may be excreted in the urine. The urea that is present in the blood can 
enter back into the rumen through the saliva.  It may also be drawn into the rumen from the 
blood down the concentration gradient. The urea can then be broken down to ammonia in the 
rumen (Reynolds, 1992). Rumen microbes require the presence of ammonia for growth and 
microbial protein synthesis. Maintaining adequate concentrations of ammonia can be 
energetically expensive for the cow. If little protein is available in the diet, ammonia is more 
readily absorbed through the rumen wall.  Energy must then be used to recycle nitrogen back 
into the rumen. Although nitrogen recycling has proven useful in maintaining the animal in 
extreme conditions, this tactic has not been shown to have benefits for high production on 
dairies. Reducing the nitrogen in the diet does seem to increase the recycling process, but it does 
not upregulate as quickly as the nitrogen intake is limited (Calsamiglia et al., 2010). Therefore, 
high milk production cannot be maintained on little protein in a real-world situation (Giallongo 
et al., 2016). 
Amino Acids 
 
Amino acid concentration can be quite different in the diet depending on the ingredients 
used. A diet that is heavy in corn products will typically be low in LYS. Feeding mostly alfalfa 
generally limits the amount of MET that is available in the diet (Weiss et al., 2002). 




down and utilized by rumen microbes. This limits the amount of AA that bypass the rumen and 
become available to the cow (Koenig et al., 2001). 
There are many AA, however only 20 are used to build proteins. Out of these, 10 are 
recognized as being necessary in the diet because the cow cannot synthesize them herself. These 
are known as essential amino acids (EAA). These EAA are absorbed by the cow from microbial 
protein and RUP as well as the cow utilizing them from endogenous proteins. Every time that a 
protein is assembled, it requires the same AA. The bonding between these AA, as well as 
between side chains, is what gives proteins their shape. These proteins are then utilized in tissue 
synthesis as well as their role in many other important functions. Many nitrogen-containing 
compounds are made using AA. These include hormones, neurotransmitters, nucleotides for 
DNA and RNA, as well as many others (Schwab et al., 2010). Importantly, AA are used to 
synthesize tissue and milk proteins. They are also important for growth, maintaining body 
weight, and milk production. Amino acids may also be used for gluconeogenesis or fatty acid 
synthesis (Lobley et al., 1992). The effects of MET and LYS supplementation are greater in 
early lactation when demands for AA are high and available energy is low (Osorio et al., 2013). 
Of their many uses, milk protein synthesis uses significant amounts of AA. Mammary cells 
remove free AA that are present in the arterial blood and utilize them in the making of milk 
protein (Patton et al., 2015). However, mammary cells are not always as efficient as is 
necessary. 
In fact, as the supply of AA increases, the efficiency at which the body uses these AA 
decreases (Vyas et al., 2009). This happens as the metabolic pathways for AA become saturated. 
As requirements are reached for the mammary gland, AA may be oxidized by the liver and used 




the use of AA by gut epithelial cells and by inefficient reabsorption of endogenous sources (Vyas 
et al., 2009).  In one study by Lee et al. (2015), a negative relationship between supply of AA 
and the efficiency at which the AA was used for milk protein synthesis was found to be larger 
than expected. When LYS and MET were supplied at 50% of dietary requirement, utilization of 
these AA for milk protein synthesis was at 90%. On the other hand, when 125% of dietary 
requirement was fed, efficiency of utilization was found to be only 60%. As the percentage of 
AA supplied exceeds the needs of the animal, the metabolic pathways become overwhelmed. 
The excess AA will be excreted and lost. This decreases the overall efficiency of utilization (Lee 
et al., 2015). Even so, meeting the dietary optimum of AA concentration is still important. 
When insufficient AA are supplied, cows can only maintain themselves so long before problems 
arise. Deficiencies of AA in the diet lead to tissue mobilization (Giallongo et al., 2015). After a 
period of time, production will also be negatively affected by inadequate AA in the diet. 
Decreased protein or AA can also cause other animal or environmental effects. Decreased 
immunity may be seen when dietary AA are insufficient (Giallongo et al., 2016). Supplying a 
greater amount of AA to the small intestine for absorption increases the amount of protein 
synthesis in the mammary gland. In a study by Ordway et al. (2009), they found that 
supplementing MET both prepartum and postpartum seemed to prevent protein loss from body 
tissues. This may help maintain health and longevity of the animal. Furthermore, supplementing 
MET and LYS improves the concentration of EAA while allowing the overall RUP of the diet 
to be reduced (Ordway et al., 2009). This means that less nitrogen will be excreted into the 
environment. Thus, the health of the environment can also be maintained.  One study by Lee et 




supplemented with MET and diets that were supplemented with LYS and MET showed an 
average decrease of 19% in ammonia emissions. 
Methionine 
 
Methionine is an AA that is important in many different processes. It is utilized in 
synthesizing proteins, but it is also important as a source of methyl groups.  Methionine is used 
to make cysteine, taurine, creatine, phosphatidylcholine, and carnitine. It also plays an important 
role in gene expression because MET is used to methylate cytosine and histone (Bertoli et al., 
2013). According to NRC (2001) recommendations, MET should be supplied 2.4% of 
metabolizable protein (MP). 
Coating Technology 
 
Free MET and LYS are rapidly degraded by microbes in the rumen (Chalupa et al., 1976. 
Onodera et al., 1993). This means that they do not make it to the small intestine where they can 
be absorbed. Researchers have spent decades testing many different types of protection methods 
to enhance the amount of AA that reaches the small intestine for absorption. Early on, many 
types of fat and fatty acid coatings were experimentally utilized. These did not prove to be 
efficient. Lipid coatings that protected MET from ruminal degradation did not release much 
MET into the small intestine for absorption (Schwab and Ordway, 2003). Mineral matrices were 
also researched. Some methods did not prove to be effective or were expensive to produce 
(Graulet et al., 2005). 
In a study by Rossi et al. (2003), hydrogenated fatty acids, calcium soaps, ethyl-cellulose, 
and pH sensitive polymers were all tested as protective coating methods. The pH polymer 
showed the most protection in this study. The ethyl-cellulose coating did reduce the nitrogen 




as the pH-sensitive polymer. According to research of Koenig et al. (2001), many types of 
coatings show a negative correlation between increased rumen protection and bioavailability of 
MET in the small intestine. The pH sensitive polymer has thus far had the most positive results 
as far as providing protection from rumen microbes without decreasing systemic bioavailability. 
Smartamine (Adisseo, Inc., Antony, France) uses a pH sensitive polymer to protect MET 
(Schwab et al., 2003). Seventy-five percent of Smartamine is a DL-MET mixture. It is 
currently a popular product due to its ability to adequately supply MET to the small intestine. 
Methionine analogs and precursors have also been studied. These increase the bioavailable 
MET by allowing the analog to pass through the rumen undegraded where it can then be 
synthesized into MET and be utilized by the cow (Koenig et al., 1999; Graulet et al., 2005). 2- 
hydroxy-4-methylthiobutanoic acid (HMB) is a MET analog.  The α-amino group of the MET 
is replaced with a hydroxyl group. This is designed to protect the HMB from rumen microbes. 
HMB can also be esterified to isopropyl ester of the 2-hydroxy-4-(methylthio)-butanoic acid 
(HMBi). Metasmart (Adisseo, Inc., Antony, France) is an HMBi product that is relatively 
popular in the market. This product contains 57% HMBi.  From the HMBi 78% can be 
converted into MET (Graulet et al., 2005). Methionine analogs and precursors have had mixed 
results and have often had low overall bioavailability (Belasco 1972; Koenig et al., 1999; Graulet 
et al., 2005). 
Attaching chemical tails to protect MET from microbial degradation has also been 
researched in some detail (Wallace et al., 1993; Baxter et al., 2001). This has proven effective 
but has often been cost prohibitive. It is therefore not currently used for dietary supplementation. 




The comparison of NALM to current commercial products is needed to verify relative 
effectiveness of various products. 
 
 
D, L isomers 
 
There are two naturally occurring isomers of MET. These are the D and L isomers. Rumen 
protected MET typically contains a mixture of these two isomers. However, D-MET must be 
converted into L-MET before it can be utilized. This process is highly inefficient (Baker et al., 
1994). The conversion of D-MET to L-MET means that the D isomer is metabolized more 
slowly, and so it accumulates in the plasma (Patton et al., 2015). The research is also unclear as 
to how much of the D isomer is actually converted into the L isomer. Furthermore, some 
research has shown that increasing the percent of L-MET in a supplement improves hepatic lipid 
metabolism in both calves as well as lactating cows (Osorio et al., 2013). 
HMB 
 
2- hydroxy-4-methylthiobutanoic acid (HMB) is not actually a rumen protected source of 
MET. It is an analog that must be absorbed and then metabolized into MET (Koenig et al., 
1999). The body tissues oxidize HMB into 2-keto-4-(Methylthio)-butanoic acid. The L-alpha- 
hydroxy acid oxidase and D-hydroxy acid oxidase enzymes are responsible for this conversion. 
It is then transaminated into MET (Graulet et al., 2005). Methionine synthesis from HMB 
occurs most actively in the liver, kidneys, rumen, and small intestine of growing lambs (Wester 
et al., 2000). 
When compared to free MET, HMB effectively delivers MET to the cow instead of rumen 
microbes. In studies by Belasco (1972), a batch culture was used to compare the analog with 




However, the ruminal protection of HMB is not as effective as many other forms of rumen 
protected MET. Koenig et al. (1999) found that about 50% of HMB bypassed the rumen. Once 
in the small intestine, it was then absorbed and converted into MET. Although 50% bypasses 
the rumen, there are further losses during the conversion from HMB to MET. Serum 
concentrations of MET peaked 6 hours post dosing with HMB (Koenig et al., 1999). 
HMBi 
 
Isopropyl ester of the 2-hydroxy-4-(methylthio)-butanoic acid (HMBi) has been shown to be 
more effective at ruminal protection than HMB. It also stimulates rumen microbes, although the 
mechanism is not yet known (Chen et al., 2011). HMBi has also been shown to increase plasma 
MET concentrations more than HMB (Ordway et al., 2009). Several studies have been 
conducted to show the method of ruminal protection and subsequent absorption of HMBi. There 
are many conflicting views. The current consensus is that much of it is absorbed across the 
rumen wall. This protects it at least in part from rumen degradation. There is also evidence that 
some HMBi makes it to the small intestine where it is absorbed. In a study by Graulet et al. 
(2005), the products of HMBi metabolism were tracked to determine how quickly it was broken 
down and absorbed.  They determined that the HMBi was absorbed rapidly across the rumen 
wall and then hydrolyzed into HMB and isopropyl alcohol. HMB is then converted into MET 
by tissues of the cow and isopropyl alcohol is converted into acetone by the liver (Wester et al., 
2000). In a study by Graulet et al. (2005), isopropyl alcohol increased in the plasma during the 
first 2 hours after HMBi supplementation. It was then slowly but steadily cleared by the liver. 
There was also a rapid increase in acetone concentrations. Both of these metabolites returned to 
normal plasma concentrations within 40-46 hours after supplementation. HMB was detectable 




an hour later. HMBi was never detected in the peripheral blood during this study. This may 
indicate that it was absorbed across the rumen wall and quickly hydrolyzed into HMB. 
Methionine concentrations in plasma increased during the 3 hours after HMBi supplementation. 
It then decreased back to basal concentrations within 48 hours. When compared with normal 
MET kinetics, it was determined that HMBi was absorbed across the rumen wall and then 
converted to MET. The ability for HMBi to be absorbed from the rumen is likely due to 
lipophilic properties. It is not yet known if HMBi is hydrolyzed within the digestive tract, in the 
digestive wall, or in the liver. Ultimately, 50% of HMBi was shown to bypass the rumen and 
therefore avoid microbial degradation (Graulet et al., 2005). In a study by Noftsger et al. (2005), 
only 2.3% of HMBi escaped from the rumen and was detectable in the omasum. But, significant 
absorption from the rumen would have left a very low concentration for passage. Furthermore, 
the group treated with HMBi in this study had higher milk protein. It was reasoned that the 
increase in milk protein would have been due to ruminal absorption of HMBi. 
Smartamine 
 
Because of its size and weight, Smartamine moves with the small, solid particles through the 
rumen. A study by Schwab and Ordway (2003) showed that as much as 90% of Smartamine 
bypassed the rumen into the abomasum. When the pH becomes more acidic in the abomasum, 
the MET is released from its capsule. The majority of it is then absorbed from the jejuno-ileal 
area in the small intestine (Graulet et al., 2005). The amount of Smartamine that is available 
varies somewhat. The availability of Smartamine is generally around 80%. Robert and Williams 
(1997) found that it ranged between 75 and 97%. 
In a study by Graulet et al. (2005), HMBi and Smartamine were compared to see the 




availability of HMBi was estimated to be 48.3 ± 2.05%. The kinetics of absorption seen in this 
trial suggested that HMBi was absorbed across the rumen wall. Methionine concentrations in 
blood peaked after 4 h and held steady for 4 more h. It then decreased steadily and returned to 
basal concentrations within 30 h after supplementation. For Smartamine, the MET availability 
was estimated to be 74.4 ± 2.15%. Methionine concentration did not increase in the blood until 
10 h after supplementation. It then increased rapidly for 2 h and remained steady for 16 h. The 
height of the peak concentration did not differ between treatments, but the area under the curve 
was 1.87 times greater for HMBi (Graulet et al., 2005). 
NALM 
 
Little research has been done on acetylated MET. The acetyl group that is attached to the 
MET prevents deamination by rumen microbes (Wallace, 1992). Once it bypasses the rumen 
and enters the small intestine, the AA and acetyl group are separated by an enzyme called 
aminoacylase 1 (Baxter et al., 2001). Hydrolysis of the acetylated MET allows its absorption by 
the small intestine. 
Liver Metabolism 
 
Much research has been done to determine AA metabolism in the liver. Evidence shows 
that the liver may use significant amounts of AA (Patton et al., 2010). It extracts AA from the 
blood once the needs of the mammary gland have been met. High concentrations of MET may 
constrict the blood flow to the mammary gland (Patton et al., 2010). Methionine is used for 
many different processes in the liver. It is used as a methyl donor for choline synthesis and 
therefore helps in the formation of very low-density lipoproteins (VLDL) (Sharma et al., 1988). 
In a study by Osorio et al. (2013), MET seems to alleviate the stress of fatty liver and ketosis. 




liver becomes overloaded with these long-chain fatty acids (LCFA). The incomplete oxidation 
of these fatty acids results in the formation of ketone bodies. Supplementation with MET 
decreases the incidence of ketosis by preventing the accumulation of triacylglycerides (Osorio et 
al., 2013; White 2015). 
Isopropyl alcohol increased quickly in plasma after HMBi supplementation. It is then 
cleared by the liver where it is converted it into acetone (Graulet et al., 2005). The body can then 
use acetone for hepatic gluconeogenesis or it can be utilized in the milk.  Acetone can be 
returned to the rumen via blood capillaries in the rumen wall. It may also be secreted back into 
the rumen via saliva.  The rumen environment allows it to be reduced back into isopropyl 
alcohol.  This can create a metabolic cycle that favors the transfer of reducing hydrogens from 
the rumen to the liver (Graulet et al., 2005). 
Utilization 
Methionine is the most limiting EAA for milk protein synthesis. Feedstuffs do not provide 
adequate MET in the diet. High producing cows may require as much as 50 to 60 g of 
supplemental MET per day (Koenig et al., 2001). In studies that have researched the effects of 
rumen protected MET, results have been inconsistent. According to Patton et al. (2010) milk 
protein percentage and milk fat percentage seems to have increased for rumen protected MET 
diets in most studies, but some studies showed no result. Studies have seen an increase of milk 
fat yield while others have found a decrease in milk fat yield (Patton et al., 2010). 
Comparing different supplementation strategies can be difficult because of differences in 
protection methods. Ration formulations also vary from one study to the next. There have been 
many inconsistencies in research results for rumen protected MET. Many of these could 




breed, and health status may affect MET utilization. Therefore, it is important to note that the 





With MET supplementation, DMI has been shown in some studies to increase and in others 
to remain the same (Patton et al., 2010). The base diets fed vary so widely, that these 
discrepancies are often attributed to diet differences. In a study by Chen et al. (2011), 
Smartamine and HMBi were compared. In this study, the LYS:MET ratio was 3:1. There were 
not any DMI effects seen for either treatment when compared with a positive 0 g dose diet. 
There were also not any differences in BW gain. 
 
Smartamine and Metasmart –an HMB product- were compared in a study by Osorio et al. 
(2013), and it was found that cows given MET supplements had greater DMI postpartum and 
lower BCS than cows that were not given supplementation. There were not significant 
differences between the two products. Mepron is a DL-MET that is protected by ethylcellulose 
and has been shown to decrease DMI when compared to Smartamine (Patton et al., 2010). 
Milk 
 
In a meta-analysis done by Patton et al. (2010), cows fed alfalfa-based diets while being 
supplemented with MET tended to have a greater increase in milk. Diets that were high in 
energy resulted in less changes in milk protein percentage between treatments. There are also 
differences in the protected MET products that were used in the studies. The varying 
bioavailability of these products would explain some of the differences in results. Giallongo et al 
(2016) also hypothesized that the mixed reports on milk fat content could also be as a result 




(2013) discovered that the cows that were fed MET had an increase in milk yield, milk protein 
percentage, energy corrected milk, and milk fat yield despite having a lower BCS than 0 g dose 
cows. 
When comparing Metasmart and Smartamine, Ordway et al. (2009) discovered that milk 
conversion from DMI and the ratio of feed nitrogen that became milk nitrogen was lower for 
Metasmart. It was hypothesized that this was due to the fact that Metasmart must be converted 
from HMBi into MET before it can be utilized. However, HMBi increased energy-corrected 
milk and milk protein content. It was hypothesized that this may be due to an increase in 
microbial protein synthesis. Both MET supplemented diets and the positive 0 g dose diet 
increased milk fat and true protein. Nitrogen efficiency was increased the most in the diet that 
was supplemented with Smartamine. Cows supplemented with Smartamine had higher plasma 
AA and milk protein. No milk yield differences were observed between HMBi and Smartamine 
when the two MET sources were compared by Chen et al. (2011). When compared with 
Smartamine, Mepron increased milk production according to Patton et al. (2010). Some studies 
have shown that HMB increases milk and milk fat yields, but no increases in milk protein 
concentration have been observed (Ordway et al., 2009). 
Immunity 
 
In a study by Osorio et al. (2013), the immune capacity increased with MET 
supplementation. The lymphocytes seem to have a MET requirement for proliferation. This 
was measured by the amounts of blood neutrophil phagocytosis that occurred. So, it should be 
understood that MET that is used for other processes in the body will not be available for use in 





Lysine, like other AA has many uses in the body. Similar to MET, it is necessary for 
growth, and milk protein synthesis. It is also used for repairing and maintaining tissues. Some 
research shows that it is necessary for gestation. Lysine is also used to make carnitine. Fat is 
transported into cells by carnitine (Evans et al., 2015). The NRC (2001) recommends that LYS 
be included in the diet of dairy cattle at a 7.2% of MP. 
LYS Coating 
There is limited information available on the LYS products and their respective 
availabilities (Evans et al., 2015). This is partially due to the fact that LYS has proven more 
difficult to coat and protect than MET. Lysine is highly water soluble (Watanabe et al., 2003). 
The positive charge on LYS may make it more reactive with coatings made of fat. Even when 
coated in the same manner as MET, it has comparatively higher rates of ruminal degradation 
(Rossi et al., 2003). Protecting LYS from rumen degradation is vital, as little more than 3% 
passes through into the lower digestive tract (Robinson et al., 2006). Amos and Evans (1978) 
found that only 5% of L-Lysine-HCl bypassed the rumen. The most common method of LYS 
protection is to coat it with lipid. Several different fatty acid combinations have been used over 
the years. Current lipid coatings appear to protect LYS from ruminal degradation. Lipid 
coatings that use saturated, long chain fatty acids also raise the melting temperature and increase 
the shelf life by preventing auto-oxidation (Sakkers et al., 2013). This makes it easier to store 
and transport. It is hypothesized that this method of protection is also the reason that LYS is not 
sufficiently released into the intestine and, therefore, is not absorbed well (Wu et al., 2012). 
Some research has suggested that acetylating the N terminus of LYS would be an effective 
method of protection. Microbes in the rumen break proteins and amino acids down with the 
enzyme aminopeptidase (Wallace et al., 1993). This means that blocking access to the amine 




appeared to be sufficient in nutrition trials, the high cost of production has prevented acetylated 
 
LYS from entering the market (Wallace et al., 1993). 
 
Elwakeel et al. (2015) tested hydroxymethyl LYS in sheep. Hydroxymethyl LYS is created 
by reacting Lysine-HCl with formaldehyde in a solution of calcium hydroxide. This study 
showed that hydroxymethyl LYS was well protected from ruminal degradation. However, it also 
inhibited ruminal microbes to the extent that the overall results were ineffective (Elwakeel et al., 
2015). 
Forms and availability 
Lysine is present in fair amounts in many animal by-products, but plants are not a good 
source. Lysine is typically low in diets that are high in corn-based ingredients. As with other 
amino acids, LYS that is available in the diet is often degraded and then utilized by rumen 
microorganisms (Evans et al., 2015). For this reason, supplements have been created that 
ruminally protect LYS. This allows farmers to supply cows with adequate amounts of LYS 
(Evans et al., 2015). In a study by Rossi et al. (2003), several types of protection were 
compared. Lysine that was protected using calcium soaps were degraded more than those that 
were protected using triglycerides. Another study tested the effects of using different 
concentrations of oleic acid in the lipid matrix (Wu et al., 2012). The LYS was protected with a 
hydrogenated fat coating that had either 2% or 4% oleic acid. The results of this study indicated 
that increasing the percentage of oleic acid in the coating decreased ruminal bypass of the 
product. Increasing the percent of LYS present in the product also decreased how much was 
able to bypass the rumen. 
It has proven difficult to protect LYS from microbes and yet maintain its bioavailability for 
the cow. This AA has been shown to be sensitive to Maillard reactions.  Furthermore, LYS 




(Sakkers et al., 2013). Watanabe et al. (2003) conducted a study using a LYS product that was 
protected with a coat of dehydrogenated tallow. The AA was tested in a solution that simulated 
rumen conditions and then in a solution that simulated abomasal conditions. In this study, 75% 
of LYS remained stable for 24 hours in solution with a pH similar to that of a typical rumen. 
However, only 2% was released in the solution with a pH similar to that of the abomasum.  In 
the aforementioned study by Wu et al. (2012), the bioavailability of LYS protected by 
hydrogenated fats in the small intestine was also tested. The hypothesis was that polyunsaturated 
fatty acids would improve the intestinal digestibility and therefore bioavailability of the LYS. It 
was discovered, however, that there was no significant increase of intestinal digestibility when 
higher concentration of oleic acid was used to protect LYS. This, combined with the decreased 
rumen bypass rate showed that increasing oleic acid was not effective. 
Wallace et al. (1993) compared two acetylated products with unmodified peptides in order 
to see the difference in rumen bypass rate. This study found that acetylated LYS (N-ɛ-methionyl 
LYS) and acetylated MET were more stable than the unacetylated peptides. This increased the 
proportion of amino acid that passed through the rumen into the lower digestive tract. 
Lactation 
A study by Giallongo et al. (2016) tested a diet with several different amounts of AA 
supplementation. The basal diet was deficient in MP. In the cows that were only supplemented 
with LYS, there was an increase in milk protein yield and plasma glucose concentration. When 
adequate amounts of MET and histidine were also supplied with LYS supplementation, milk fat 
yield, ECM and feed efficiency were also increased. 
DMI 
 
Dry matter intake was decreased for the LYS supplemented diet in the study by Giallongo 




when the diet was supplemented with LYS (Paz et al., 2013). Effects vary from study to study 
based on diets, stage of lactation, and many other factors. 
 
 
Cobalt as a marker 
 
Cobalt leaves the rumen with the liquid portion of the diet. Since NALL and NALM are 
quickly dissolved in liquid, they also pass through the rumen with the rest of the liquid. Cobalt 
can be used effectively to determine the rumen bypass rate of NALL and NALM because it 




Balancing AA in the diet of dairy cows is necessary in order to maintain milk production 
and milk protein synthesis. There have been many methods for protecting AA from ruminal 
degradation over the last few decades. The improved protection allowed for more AA to become 
available for absorption from the small intestine. The AA must be released from the coating 
method before it can be absorbed. Results for overall bioavailability have been variable; 
especially for LYS.  It is believed that attaching chemical tails to the α-amino group of AA 
would improve overall bioavailability. Three experiments were designed to test the overall 
availability of one rumen protected MET product and two rumen protected LYS products. 
Rumen bypass and duodenal appearance were measured. Blood AA concentration was 
monitored so that blood AUC could be calculated. Milk yield, milk protein, milk fat, and DMI 
were measured. It was hypothesized that NALM would protect the MET from ruminal 
degradation while allowing for release in the small intestine. It was also hypothesized that the 




doses of ƐNALL. It was hypothesized that the chemical tail would provide protection in the 
rumen and be cleaved from the LYS in the small intestine. Milk protein synthesis and milk yield 
was hypothesized to increase in response to LYS supplementation. The second experiment with 
NALL compared ƐNALL and diNALL. It was hypothesized that the two NALL products 
would have similar bioavailability and production effects. These experiments were designed to 
test the ruminal protection and intestinal digestibility of NALM and NALL, as well as the 













Rumen protected Methionine (MET) is critical for milk protein synthesis in dairy cows. N- 
acetyl-L-methionine (NALM) is a MET derivative that consists of L-MET protected with an 
acetyl group that is attached to the α-amino group. The objective of this study was to quantify 
the gastrointestinal availability of NALM by measuring ruminal escape and intestinal 
appearance. The experiment was designed as a 3 × 3 Latin square using 3 lactating Holstein 
cows that had been fitted with cannulas in the rumen and duodenum. Each cow was fed twice 
daily with a diet that consisted of alfalfa hay, corn silage, steam-flaked corn, cottonseed, canola 
meal, soybean meal, shredded beet pulp, and a vitamin and mineral mix. The cows were fed this 
diet for 2 weeks leading up to the experiment so that the rumen microbes had time to adapt. 
Each period consisted of 10 d of adaptation followed by 2 d of sampling.  A dose of 0 g 
(control), 30, or 60 g of NALM was placed under the rumen mat at the time of feeding every day 
during adaptation and hour 0 of the sampling period. On the first day of sampling, a liquid 
marker (Co-EDTA) was also administered as a bolus dose at the time of NALM administration. 
Blood, ruminal, and duodenal samples were then taken at hours 0, 1, 3, 6, 9, 12, and 24 after 
administration of the NALM and liquid marker. A nonlinear regression model was used to 




NALM from the rumen. There was no difference between treatments for liquid passage rate or 
ruminal NALM passage rate. Ruminal escape as a percentage of the dose was numerically 
higher for the 30 g dose (69.1%) than for the 60 g dose (46.2%), but no statistical differences 
were found (P = 0.44). Duodenal NALM appearance as a percentage of dose did not differ (P = 
0.21) between the 30 g dose (2.16%) and the 60 g dose (3.40%). Dietary treatments did not 
affect rumen pH or VFA production. In conclusion, overall results suggest that NALM was 








Protein is an important nutrient for dairy cows. It is necessary to balance rumen degradable 
protein (RDP) and rumen undegradable protein (RUP) such that the microbes are supplied with 
protein to grow while the cow still receives sufficient for systemic needs (Weiss et al., 2002). 
Supplying sufficient CP is not always adequate to meet production needs. Specific AA are 
necessary in the diet (Schwab et al., 2010). Amino acids are utilized for many different purposes 
in the body, including tissue growth, milk proteins, and enzymes. Milk protein is reduced if 
insufficient AA are present in the diet (Schwab et al., 2010; Lobley et al.,1992). It is generally 
accepted that the AA that is limited most frequently in regards to milk protein synthesis in dairy 
cows is MET (Schwab et al., 2003; Weiss et al., 2002). In order to ensure that the dietary 
requirement of this AA is achieved, many methods have been developed to protect it from 
microbial degradation so that it may bypass the rumen and be absorbed from the small intestine 
of the cow (Graulet et al., 2005; Rossi et al., 2003; Koenig et al, 2001). Along with improving 
milk components, feeding bypass AA also increases the efficiency of nitrogen utilization and 
therefore decreases the deleterious effects nitrogen can have on the environment (Ordway et al., 
2009). The benefits of feeding rumen protected AA depends on the efficacy of the individual 
products to supply MET to the cow via absorption from the small intestine. The NALM product 
is a MET derivative where the MET is protected from rumen degradation by an acetyl group 
that is attached to the α-amino group of the AA (Wallace et al., 1992). The NALM product was 
tested in vitro by Wallace et al. (1992). After 48 h, 67% of the NALM was still present in the 




present study compared the extent to which NALM provided protection from rumen degradation 








Animals and Diets 
 
 
Three lactating Holstein dairy cows (second-lactation cows; 631 ± 5.9 kg BW) with ruminal 
(10 cm diameter, Bar Diamond, Parma, ID) and duodenal T-type (Bar Diamond, Parma, ID; 
placed 10 cm distal to the pylorus) cannulas were used in an experiment of 3 X 3 Latin square 
design. Cows were adapted to the basal diet for 2 weeks before beginning the experiment. Each 
of the 3 periods consisted of 10 d adaptation and 48 h sampling. 
All care and procedures were approved by the Institutional Animal Care and Use Committee of 
Utah State University. Cows were housed in individual tie stalls. Each stall had a rubber mat 
that was bedded daily with straw. Clean water was accessible at all times. Cows were milked 
twice daily at 0400 and 1530 h. The DIM for the three cows averaged 22 days at the beginning 
of the trial and averaged 98 days by the end. 
The TMR was mixed daily and was composed of alfalfa hay, corn silage, straw, steam- 
flaked corn, cottonseed, soybean meal, canola meal and a vitamin and mineral mix (Table 1). 
Each cow was fed in her individual bunk twice each day at 0600 and 01600 h throughout the 
experiment. Enough TMR was given so that approximately 10% orts were left each morning. 
Cows were supplemented with 0, 30, or 60g NALM each day of the adaptation period and hour 
0 of the sampling period. Supplements were placed through the rumen cannula, beneath the 




Table 1. Ingredients and chemical composition of the experimental diets with varying does of N- 
acetyl-L-methionine supplemented to early lactation Holstein dairy cows.  
  Diet  
Item 0 g/d NALM 30 g/d NALM 60 g/d NALM 
Ingredient, % of DM    
Alfalfa Hay 29.35 29.31 29.28 
Corn Silage 27.08 27.04 27.01 
Wheat Straw 3.22 3.22 3.21 
Corn, steam-flaked 12.31 12.29 12.28 
Cottonseed, whole 5.30 5.30 5.29 
Canola meal 6.91 6.90 6.89 
Soybean meal 6.91 6.90 6.89 
Beet pulp, shredded 5.11 5.11 5.10 
Vitamin and mineral mix 2.67 2.67 2.66 
Sodium bicarbonate 1.14 1.13 1.13 
NALM 0 0.12 0.25 
Chemical composition, % of DM 
DM, % 96.7 96.7 96.7 
OM 88 88 88 
CP 15.8 15.8 15.8 
NDF 38.5 38.5 38.5 
ADF 25.7 25.7 25.7 
Ether Extract 1.5 1.5 1.5 
LYS, %MP 6.78 6.74 6.70 
MET, %MP 1.92 2.29 2.67 






Each period consisted of 10 days of adaptation followed by 48 h of sampling.  The amount 
of TMR fed and refusals were recorded every day of the entire trial.  Samples of the TMR and 
of individual refusal were taken from day 5 of adaptation through day 2 of sampling. These were 
dried and ground. Body weights for each cow were taken on days 9 and 10 of each adaptation 
period. A liquid marker of Co-EDTA was given ruminally at the same time as the NALM was 




according to instructions given in Uden et al. (1980) and was then dissolved in 500 mL of 
distilled water so that each dose contained 3 g of cobalt. 
Rumen, duodenal and blood samples were taken at 0, 1, 3, 6, 9 ,12, and 24 h after the cobalt was 
given on the first day of sampling. Rumen samples were taken from various parts of the rumen 
through the cannula. This was then strained to remove solids and microbes. Samples were then 
acidified with 6 M HCl for ammonia analysis, or HPO3 for VFA analysis and frozen (-40ºC). 
Duodenal contents (100 ml) were collected and frozen for later analysis. The pH of rumen and 
duodenal contents was measured at each sampling.  At 48 h, the rumen contents of the cows 
were removed and then weighed. The rumen contents of each cow were then placed into the 
rumen of the cow that would be the next to receive the corresponding supplementation. This was 
intended to expedite the adaptation process for the rumen microbes. A sample was taken and 
dried in a 60º C oven until dry to determine dry matter content. Blood was collected from the 
coccygeal vein into purple top Vacutainer tubes, centrifuged at 3000 X g for 25 min.  Plasma 
was removed from the cells and then frozen until analyzed. Blood plasma was also collected for 
blood ketone and glucose analysis 0 and 24 h after Co-EDTA administration. 
Milk yield was recorded daily from 14 d before the first adaptation until the end of the 
experiment. Milk samples were taken a.m. and p.m. of the 2 sampling days and preserved with 
potassium dichromate and analyzed for fat, protein, lactose, somatic cell count, and MUN by 







All TMR and refusal samples were dried in a 60◦ C oven for 48 h and weighed to determine 
DM. They were then ground through a 1-mm screen for analysis. Both NDF and ADF were 
analyzed according to standard procedures using an Ankom 2000 Fiber Analyzer (Ankom 
Technology, Macedon, NY). These procedures were based upon the research and fiber analysis 
work by Van Soest and Robertson (1980). Approximately 0.9-1.0 g from ground sample was 
sealed in an Ankom XT4 bag and analyzed for fat content using an XT15 ether extract machine 
(Ankom Technology, Macedon, NY). Each sample was extracted for 40 min at 70°C and then 
dried at 102°C for 16 hr. Percentage fat was determined as mass lost after extraction and drying. 
Rumen and duodenum samples (100 ml) were freeze dried and then ground using a mortar 
and pestle. These samples were then sent to CJ CheilJedang Bio (Seoul, South Korea) for MET 
and cobalt analyses. Each sample was diluted (X 40 dilution) using deionized water and 
vortexed until dissolved. These samples were then sonicated for 20 min. The solution was 
centrifuged for 20 minutes at 4000 X g. The supernatant was filtered through a 0.45 µL syringe 
filter and then analyzed for NALM concentration using UHPLC (Shimadzu Nexera, Seoul, 
South Korea). An additional 0.1 g of each ground sample was dissolved in 4 mL nitric acid, 4 
mL water, and 2 mL hydrogen peroxide before being digested by acid assisted microwave 
irradiation using an Ethos Easy digestor system (Milestone Srl, Sorisole, Italy) for 30 min at 
200° C. These samples were then diluted with 50 mL deionized water and tested for cobalt 
concentration with plasma mass spectrometry (ICP-MS, Agilent, Santa Clara, CA). 
Each rumen sample was analyzed for NH3-N. First, 2-3 mL of rumen fluid was spun in a 




of distilled water and vortexed. Twenty µL of the solution was then placed in a microwell. Each 
sample was mixed with reagents made of phenol, sodium nitroprusside, sodium hydroxide, 
sodium hypochlorite, and ammonium sulfate. The preparation of the reagents and the procedure 
of mixing them with the samples was done according to the protocols established by 
Weatherburn (1967). After mixing with the reagents, the samples were run in an MRX 
microplate reader (Dynatech, Alexandria, VA). 
Blood MET was determined using EZ:faast (Phenomenex, Torrance, CA) reagents and 
protocol for gas chromatography. Rumen samples were prepared for analysis by centrifugation 
at 12000 X g for 10 minutes. The supernatant was analyzed for MET using a Hewlett-Packard 
6890 GC (Agilent, Santa Clara, CA) as explained by Eun and Beauchemin (2007). 
 
 
Calculations and Statistical Analysis 
 
 
The fractional rate constants for the cobalt marker and the MET were determined by 
running nonlinear regression analysis in SAS 9.4. The NALM is soluble in liquid. It dissolves 
quickly and is assumed to pass with the liquid portion of the rumen. The fractional rate constant 
of NALM was equated to that of the liquid cobalt marker. 
The calculations and statistical analysis for fractional rate constants, ruminal disappearance, 
duodenal appearance, and duodenal area under the curve (AUC) were run according to the 
protocol set in Koenig et al. (2002). 
Data for DMI, milk yield, milk protein, milk fat, and blood parameters were run using a 
Latin square mixed linear model (PROC MIXED; SAS 9.4). Treatment and period were run as 




RESULTS AND DISCUSSION 
 
 
No differences were seen in milk yield and composition between treatments (Table 2). This 
may have been due in part to the fact that the experimental periods were short. Research into 
MET supplementation shows varying results for milk production. In a meta-analysis of MET 
trials, Patton et al. (2010) found that milk fat and milk protein increased in response to MET in 
some trials but decreased in other trials. The varied response of milk fat may be due to the many 
alternate uses of MET in the body (Giallongo et al., 2016). Results for milk yield also varied 
between trials. Some trials did not see any differences in milk yield (Osorio et al., 2013; Chen et 
al., 2011; Ordway et al., 2009). No decreases in DMI were recorded in response to NALM 
treatment (Table 2). This seems to indicate that no feedback mechanisms were triggered by 
NALM that would decrease appetite - at least not during the length of this trial. Previous 
research observed differing responses of DMI to MET supplementation (Osorio et al., 2013; 
Chen et al., 2011). 
 
Table 2. Dry matter intake, body weight, and milk parameters of second lactation dairy cows 
fed rumen protected methionine.1 
 
 0 g 60 g 30 g SEM P 
DMI (kg/day) 30.0 31.8 31.1 7.36 0.33 
Milk Protein 2.8 2.8 2.8 0.07 0.42 
Milk Fat 3.8 3.5 3.5 0.20 0.22 
Lactose 4.7 4.7 4.7 0.08 0.78 
SNF 8.3 8.3 8.3 0.12 0.18 
SCC 18.2 17.8 10.8 8.96 0.33 
MUN 14.6 14.6 14.4 0.66 0.89 
Yield (kg/day) 28.6 28.6 27.3 8.76 0.28 
BW (kg) 641.6 645.6 645.9 21.79 0.29 




Rumen pH and VFA production did not differ between treatments. There was a trend 
for rumen pH to be higher for the 0 g dose than for the NALM treatments (Table 3; P = 0.09). 
Although it appears that the NALM was splitting prior to the duodenal sampling site, there was 
no significant increase in blood MET AUC between treatments (Table 3; P = 0.43). The AUC 
60 g dose was numerically lower than the 30 g dose and the 0 g dose (Table 3; 1610, 2162, and 
2361 respectively). This may indicate that the body absorbed and utilized the MET that it 
needed. Previous research on AA absorption has indicated that increased supplementation 
results in decreased efficiency of absorption of the AA (Vyas et al., 2009). The 60 g dose may 
have been high enough that the need for MET was exceeded and the absorption pathways down- 
regulated. This has been seen in previous research on AA absorption (Vyas et al., 2009; Lee et 
al., 2015). 
 
Table 3. Ruminal pH, ammonia-N, VFA profiles and blood methionine AUC of second lactation 
dairy cows fed a diet with rumen-protected methionine1 
 
 0 g 60 g 30 g SEM P 
Rumen pH 6.5 6.3 6.3 0.19 0.09 
Duodenum pH 2.9 3.0 2.9 0.08 0.37 
NH3-N, mg/100 
mL 7.6 7.6 7.9 0.84 0.93 
  Individual VFA, mol/100 mol  
Acetate (A) 1.2 1.1 1.1 0.05 0.21 
Propionate (P) 0.2 0.2 0.2 0.03 0.80 
Butyrate 0.1 0.1 0.1 0.01 0.36 
Valerate 0.01 0.01 0.01 0.002 0.37 
Isobutyrate 0.01 0.01 0.01 0.001 0.2 
Isovalerate 0.01 0.01 0.01 0.001 0.34 
A:P 5.0 4.7 4.8 0.22 0.03 
Blood methionine      
Baseline 124.8 117.5 68.8 33.06 0.47 
Blood MET AUC, 




1 0 g, 30 g, and 60 g of NALM (CJ). 
 
 
Liquid passage rate was determined by the concentration of a liquid cobalt marker as 
described in Koenig et al. (2002). Treatment did not affect liquid passage rate. Fractional rate 
constant of NALM going into the small intestine was not affected by treatment. Ruminal escape 
of NALM was numerically higher for the 30 g dose (69.1%) than for the 60 g dose (46.2%), but 
no statistical differences were observed (Table 4; P = 0.44). The percentage of NALM that 
escaped the rumen was roughly that noted in vitro by Windschitl et al. (1988). Duodenal 
appearance was low (2.16%-3.40%) but did not differ significantly between treatments (Table 4; 
P = 0.21). These results are relatively consistent with findings from Koenig et al. (2010). 
Duodenal appearance of NALM may have appeared low due to the fact that the acid 
environment of the abomasum and aminoacylase 1 in the small intestine split the acetyl group 
from the MET (Baxter et al. 2001). This allows for MET to be absorbed in the small intestine. 
Low duodenal appearance may indicate that the acetyl group of NALM was indeed being 
cleaved from the MET prior to the duodenal collection, as intended. 
 
 
Table 4. Ruminal escape and duodenal appearance of NALM in second lactation dairy cows fed 
a diet with rumen-protected methionine1 
 0 g 60 g 30 g SEM P 
Ruminal 
volume, L 
126.9 129.5 127.4 7.43 0.91 
Ruminal flow 
rate, L/h 
14.0 13.8 13.7 1.75 0.36 
Fractional rate 
constants, /h 
     
Liquid 0.113 0.108 0.107 0.016 0.65 
NALM … 0.30 0.13 0.06 0.13 
Ruminal 
escape, % of 
  dose  
























1 0 g, 30 g, and 60 g of NALM (CJ). 
 
 
The NALM product provided reasonable protection of MET from ruminal degradation. It 
appears to have been split prior to the collection site in the duodenum. Future studies are also 












Lysine (LYS) is one of the most limiting amino acids for dairy cow production. Rumen 
protected LYS is important for milk protein synthesis. Two different rumen protected LYS 
derivatives were tested in two consecutive trials. Both ƐN-acetyl-L-Lysine (ƐNALL) and Nα,Ɛ- 
acetyl-L-Lysine (diNALL) are protected from rumen degradation with an acetyl group attached 
to the α-amino group. The objective of this study was to quantify the gastrointestinal availability 
of N-acetyl-L-Lysine (NALL) by measuring ruminal escape and intestinal appearance. Two 
experiments were run as a 3 × 3 Latin square using 3 second lactation Holstein cows that had 
been fitted with cannulas in the rumen and duodenum. Each period consisted of 10 days of 
adaptation followed by 2 days of sampling. During the first experiment, a dose of 0 (0 g dose), 
60, or 120 g of ƐNALL was placed under the rumen mat at the time of feeding every day of 
adaptation and hour 0 of sampling periods. A dose of 0 (0 g dose), 120 g ƐNALL, or 120 g 
diNALL was given similarly during the second experiment. On the first day of sampling, a 
liquid marker (Co-EDTA) was also administered as a bolus dose at the time of NALL 
administration. Blood, ruminal, and duodenal samples were then taken at hours 0, 1, 3, 6, 9, 12, 
and 24 of sampling. A nonlinear regression model was used to determine fractional rate 
constants for the passage of the liquid marker and the disappearance of NALL from the rumen. 
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During experiment 1, there was no difference between treatments for DMI, milk production, 
liquid passage rate and ruminal NALL passage rate. Ruminal escape as a percentage of the dose 
was numerically higher for the 120 g dose (32.7%) than for the 60 g dose (27.2%), but no 
statistical differences were found (P = 0.54). Duodenal NALL appearance as a percentage of 
dose was higher (P < 0.01) for the 60 g dose (2.86%) than for the 120 g dose (1.19%). The 
production of acetate, butyrate, propionate, and valerate (Table 3; P < 0.01) was greater for the 
supplemented cows than for the 0 g dose cows. There was a trend for isobutyrate to be higher 
for the supplemented cows than for the 0 g dose (Table 3; P = 0.06). For experiment 2, no 
differences were seen in DMI, milk yield, and milk composition between treatments. There was 
a trend (P = 0.08) for ƐNALL to have a higher rumen pH than diNALL. There were no 
differences between treatments for fractional rate constants, ruminal escape, or duodenal 
appearance. There do not appear to be any significant differences between ƐNALL and 






It is generally accepted that dairy cows have a need for specific AA rather than a specific 
amount of CP. Lysine is an important AA that is used in milk protein synthesis as well as tissue 
growth. It is also an important player in fat metabolism due to the fact that it is used to make 
carnitine, which is essential for utilization of mobilized fat stores (Evans et. al, 2015). Lysine is 
often limited in typical dairy diets, and therefore, must be supplemented (Weiss et al., 2002). 
Very little free LYS escapes rumen degradation. As little as 3-5% of LYS supplemented in 
the free form or as a salt makes it into the lower digestive tract (Amos and Evans, 1978; 
Robinson et. al, 2006). Much research has been done to find a way to protect LYS from 
degradation in the rumen (Wallace et al., 1993; Watanabe et al., 2003; Sakkers et al., 2013; 
Evans et al., 2015). Methods that have previously worked to ruminally protect MET have proven 
inefficient for LYS protection (Rossi et al., 2003). The most common method of protecting LYS 
in the rumen is to coat the AA with a lipid complex. Lysine is more reactive than MET and 
tends to interact with the lipid matrix and this increased reactivity leads to the LYS remaining 
bound to the lipid coating in the lower digestive tract (Wu et. al, 2012). 
Studies found that blocking the amine group of AA provides adequate protection in the 
rumen while allowing for degradation in the abomasum and small intestine (Wallace et al., 1993; 
Baxter et al., 2001). This happens because attaching a chemical tail to the N terminus blocks 
rumen microbes from breaking down the AA. Lower pH in the abomasum weakens the bonds 
and allows the chemical tail and the AA to be cleaved by aminoacylase (Baxter et al., 2001). 
However, the process of chemical modification to protect AA has been cost prohibitive up to this 
point in time. But, both the ƐNALL and the diNALL are protected with an acetyl group 
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attached to the α-amino group using a more efficient process (Wallace et. al, 1993). The present 
study was intended to compare the rumen protection, bioavailability and production effects of 
these NALL products in dairy cows. 
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Animals and Diets 
 
 
Three lactating Holstein dairy cows (second-lactation cows; 735.7±33.3 kg BW for 
experiment 1 and 783.2±22.3 kg BW for experiment 2) with ruminal (10 cm diameter, Bar 
Diamond, Parma, ID) and duodenal T-type (placed 10 cm distal to the pylorus, Var Diamond, 
Parma, ID) cannulas were used in 2 experiments of 3 X 3 Latin square design with 3 periods of 
10 d adaptation and 48 h sampling. 
All care and procedures were approved by the Institutional Animal Care and Use Committee 
of Utah State University. Cows were housed in individual tie stalls. Each stall was bedded daily 
with straw. Clean water was accessible at all times. Cows were milked twice daily at 0400 and 
1530 h. The average DIM was 207-243 days for experiment 1 and 243 -307 days for experiment 
2. 
Cows were put in tie stalls and adapted to the diets for a 2-week period before the 
experiment began. The TMR was composed of alfalfa hay, alfalfa haylage, corn silage, straw, 
steam-flaked corn, high moisture corn, cottonseed, soybean/canola meal, beet pulp and a 
vitamin/mineral mix (Table 1). Each morning of the adaptation, cows were given the 
supplement under the rumen mat 15 minutes after feeding. Each cow was given the supplement 
and the cobalt marker hour 0 of sampling. The treatments were 0g (0 g dose), 60g, or 120g 
ƐNALL for experiment 1, and either 0g, 120g ƐNALL, or 120g diNALL for experiment 2. 
Each cow was fed in her individual bunk twice each day at 0600 and 01600 h throughout both 





Table 1. Ingredients and chemical composition of the experimental diets with varying does of N- 
acetyl-L-lysine supplemented to early lactation Holstein dairy cows 
   Diet  








Ingredient, % of DM     
Alfalfa Hay 17 17 17 17 
Alfalfa Haylage 14.7 14.7 14.7 14.7 
Corn Silage 8.6 8.6 8.6 8.6 
Wheat Straw 5.9 5.9 5.9 5.9 
Corn, steam-flaked 12.5 12.5 12.5 12.5 
High Moisture Corn 9.6 9.6 9.6 9.6 
Cottonseed, whole 7.3 7.3 7.3 7.3 
Canola meal 4.5 4.5 4.5 4.5 
Soybean meal 4.2 4.2 4.2 4.2 
Beet pulp, shredded 6.7 6.7 6.7 6.7 
Vitamin and mineral mix 1.9 1.9 1.9 1.9 
Sodium bicarbonate 0.6 0.6 0.6 0.6 
NALL 0 0.2 0.4 0.4 
Chemical composition, % 
of DM 
    
DM, % 94.7 94.7 94.7 94.7 
OM, % 90.3 90.3 90.3 90.3 
CP 16.4 16.4 16.4 16.4 
NDF 39.6 39.6 39.6 39.6 
ADF 24.6 24.6 24.6 24.6 
Ether Extract 3.58 3.58 3.58 3.58 
LYS, % MP 6.54 9.34 12.14 12.14 
MET, % MP 1.85 1.82 1.79 1.79 






Each period consisted of 10 d adaptation followed by 48 h of sampling. The amount of 
TMR fed and refusals were recorded every day of the entire trial. Samples of the TMR and of 
individual refusal were taken from day 5 of adaptation through day 2 of sampling. These were 
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dried and ground. Body weights for each cow were taken on days 9 and 10 of each adaptation 
period. A liquid marker of Co-EDTA was given ruminally at the same time as the NALL 
supplements (0 h of sampling). This marker was prepared according to instructions given in 
Uden et al. (1980) and was then dissolved in 500 mL of distilled water so that each dose 
contained 3 g of cobalt. 
Rumen, duodenal and blood samples were taken at 0, 1, 3, 6, 9 ,12, and 24 h after the cobalt 
and NALL were given on the first day of sampling periods. Rumen samples were taken from 
various parts of the rumen through the cannula. This was then strained to remove solids and 
microbes. Samples were then acidified with 6 M HCl for ammonia analysis, or HPO3 for VFA 
analysis and frozen (-40ºC). Duodenal contents (100 mL) were collected and frozen until 
processed for analyses. The pH of rumen and duodenal contents was measured at each sampling. 
Blood was collected from the tail vein into purple top Vacutainer tubes, centrifuged at 3000 X g 
for 25 min. The plasma was then separated from the cells and frozen until analysis.  Blood 
serum was also collected for glucose and ketone analysis in red top Vacutainer tubes at 0 h and 
24 h after Co-EDTA administration. 
Milk yield was recorded daily from 14 d before the first adaptation until the end of the 
experimental periods. Milk samples were taken a.m. and p.m. of the 2 sampling days, preserved 
with potassium dichromate, and analyzed for percent fat, percent protein, lactose, somatic cell 






All TMR and refusal samples were dried in a 60◦ C oven for 48 hours and weighed to 
determine DM. They were then ground through a 1-mm screen for analysis. NDF and ADF was 
analyzed according to standard procedures using an Ankom 2000 Fiber Analyzer (Ankom 
Technology, Macedon, NY). These procedures were based upon the research and fiber analysis 
work by Van Soest and Robertson (1980). Approximately 0.9-1.0 g from ground sample was 
sealed in an Ankom XT4 bag and analyzed for fat content using an XT15 ether extract machine 
(Ankom Technology, Macedon, NY). Each sample was extracted for 40 min at 70°C and then 
dried at 102°C for 16 hr. Percentage fat was determined as mass lost after extraction and drying. 
Rumen and duodenum samples (100 mL) were freeze dried and then ground using a mortar 
and pestle. These samples were then sent to CJ CheilJedang Bio (Seoul, South Korea) for LYS 
and cobalt analysis. Each sample was diluted (X 40 dilution) using deionized water and vortexed 
until dissolved.  These samples were then sonicated for 20 minutes.  The solution was 
centrifuged for 20 minutes at 4000 X g. The supernatant was filtered through a 0.45 µL syringe 
filter and then analyzed for NALL concentration using UHPLC (Shimadzu Nexera, Seoul, South 
Korea). An additional 0.1 g of each ground sample was dissolved in 4 mL nitric acid, 4 mL 
water, and 2 mL hydrogen peroxide before being digested by acid assisted microwave irradiation 
using an Ethos Easy digestor system (Milestone Srl, Sorisole, Italy) for 30 minutes at 200° C. 
These samples were then diluted with 50 mL deionized water and tested for cobalt concentration 
with plasma mass spectrometry (ICP-MS, Agilent, Santa Clara, CA). 
Each rumen sample was analyzed for NH3-N. First, 2-3 mL of rumen fluid was spun in a 
microcentrifuge at 12000 X g for 2 minutes. 100 µl of the supernatant was then diluted with 400 
46 
 
µL of distilled water and vortexed. 20 µL of the solution was then placed in a microwell. Each 
sample was mixed with reagents made of phenol, sodium nitroprusside, sodium hydroxide, 
sodium hypochlorite, and ammonium sulfate. The preparation of the reagents and the procedure 
of mixing them with the samples was done according to the protocols established by 
Weatherburn (1967). After mixing with the reagents, the samples were run in an MRX 
microplate reader (Dynatech, Alexandria, VA). 
Blood LYS was determined using EZ:faast (Phenomenex, Torrance, CA) reagents and 
protocol for gas chromatography. Rumen samples were prepared for analysis by centrifugation 
at 12000 X g for 10 minutes. The supernatant was analyzed for LYS using a Hewlett-Packard 




Calculations and Statistical Analysis 
 
 
The fractional rate constants for the cobalt marker and for the NALL were determined by 
running nonlinear regression analysis in SAS 9.4. The NALL products dissolve quickly in the 
rumen fluid. Therefore, the rate of passage from the rumen was assumed to be equal to that of 
the liquid marker. 
The calculations and statistical analysis for fractional rate constants, ruminal disappearance, 
duodenal appearance, and duodenal area under the curve (AUC) were run according to the 
protocol set in Koenig et al. (2002). 
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Data for DMI, milk yield, milk protein, milk fat, and blood parameters were run using a 
Latin square mixed linear model (PROC MIXED; SAS 9.4). Treatment and period were run as 
fixed effects, and cow was run as a random effect. 
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RESULTS AND DISCUSSION 
 
 
There were no significant differences in DMI and milk yield for experiment 1 (Table 2). 
Milk production parameters such as protein and fat were also not altered significantly during 
experiment 1 (Table2). Some of this may have been due to the short length of the test period. 
The lack of effect on milk protein could also be attributed to the stage of lactation. Dairy cows 
are more sensitive to AA supplementation during early lactation when their needs are typically 
greater than their intake (Calsamiglia et al., 2010; Lee et al., 2015). 
 
 
Table 2. Dry matter intake, body weight, and milk parameters of second lactation dairy cows 
fed rumen protected lysine1 
 0 g 120 g 60 g SEM P 
DMI (kg/day) 36.5 36.7 37.0 2.22 0.89 
Milk Protein 3.2 3.3 3.2 0.08 0.60 
Milk Fat 3.7 3.8 3.9 0.32 0.60 
Lactose 4.2 4.3 4.2 0.16 0.47 
SNF 8.2 8.4 8.3 0.21 0.48 
SCC 201.5 187.3 175.1 55.55 0.74 
MUN 13.6 15.0 14.5 0.64 0.12 
Yield (kg/day) 27.7 26.8 26.5 6.99 0.43 
BW (kg) 740.2 727.5 738.6 15.96 0.09 
10 g, 60 g, and 120 g of ƐNALL (CJ Bio). 
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During experiment 1, we observed a numerically greater percent of the 120 g dose of NALL 
escaped the rumen (Table 4; 32.7%) than the 60 g dose (Table 4; 27.2%). This could be 
explained by the greater concentration of NALL in the rumen and a saturation of breakdown 
capacity. A greater percent would be expected to escape the rumen microbes. This difference 
was not statistically significant. 
Blood LYS AUC was greater for the 0 g dose than the supplemented groups during 
experiment 1. We observed greater blood LYS AUC for the 120 g dose than for the 60 g dose 
(Table 3, P = 0.02). The higher blood LYS AUC for the 0 g dose may indicate that the chemical 
tail was not cleaved properly. The dosage of LYS may have been high enough to cause a 
downregulation of LYS absorptive pathways, which has been seen in previous research (Vyas et 
al., 2009). Acetate, propionate and valerate production was higher (Table 3; P < 0.01) for the 
supplemented groups than for the group that was given 0 g NALL. Butyrate production was 
significantly higher (Table 3; P < 0.01) for the 120 g dose of ƐNALL than for the 0 g dose. We 
noted a trend (Table 3; P = 0.06) for isobutyrate production to be higher in the group 
supplemented with 120 g of ƐNALL than for the 0 g dose. The 0 g dose group had a higher 
acetate to propionate ratio (Table 3; P < 0.01) than the group supplemented with the 120 g dose. 
An increase in VFA production seems to indicate that the ƐNALL that was not protected was 
being used by the rumen microbes. Increased VFA production leads to increased energy 
available for use by the cow. This increase in VFA production in response to supplementation 
may be responsible for the increase in milk production and milk fat seen in other research 
(Giallongo et al., 2016). We observed a higher acetate to propionate ratio for the 0 g dose than 
for the 60 g or 120 g doses (Table 3; P < 0.01). The lower acetate to propionate ratio coupled 
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with the overall increase in VFA production for the cows supplemented with LYS means that 
there is more propionate available for gluconeogenesis. 
 
 
Table 3. Ruminal pH, ammonia-N, VFA profiles, and blood lysine concentration in second 
lactation dairy cows fed a diet with rumen-protected lysine1 
 0 g 120 g 60 g SEM P 
Rumen pH 6.28 6.05 6.20 0.150 0.23 
Duodenum pH 2.86 2.88 3.02 0.147 0.71 
NH3-N, mg/100 mL 5.60 5.61 5.48 0.608 0.97 
Individual VFA, mol/100 mol 
Acetate (A) 0.60 0.70 0.67 0.043 <0.01 
Propionate (P) 0.19 0.25 0.23 0.027 <0.01 
Butyrate 0.13 0.16 0.14 0.015 <0.01 
Valerate 0.018 0.022 0.021 0.0017 <0.01 
Isobutyrate 0.011 0.012 0.012 0.001 0.06 
Isovalerate 0.02 0.02 0.02 0.002 0.21 
A:P 3.13 2.85 2.99 0.1 <0.01 
Blood Lysine      
Baseline 157.3 123.3 134.6 60.78 0.57 
Blood LYS AUC, 
µM/L 
2624 2222 2108 314.3 <0.01 
10 g, 60 g, and 120 g of ƐNALL (CJ Bio). 
 
 
We observed a trend (Table 4; P = 0.07) for the 60 g dose to have a higher duodenal AUC of 
 
NALL than the 120 g dose. A higher percentage of NALL appeared in the duodenum for the 60 
51 
 
g dose than for the 120 g dose (Table 4; P < 0.05). Rumen flow was numerically lower for the 
120 g dose (Table 4; 16.3) than for the 60 g dose (Table 4; 18.9). This slower escape from the 
rumen may have allowed enzymes to more completely break down the NALL before it reached 
the duodenum. This would result in a lower AUC and duodenal appearance of NALL for the 
120 g dose than for the 60 g dose. 
 
 
Table 4. Ruminal escape and duodenal appearance NALL in second lactation dairy cows fed a 
diet with rumen-protected lysine1 
 0 g 120 g 60 g SEM P 
Ruminal flow 
rate, L/h 
18.0 16.3 18.9 2.78 0.12 
Fractional rate 
constants, /h 
     
Liquid 0.14 0.13 0.14 0.022 0.91 
Ruminal 
NALL 
… 0.45 0.52 0.066 0.51 
Ruminal 
escape, % of 
dose 









… 1.2 2.9 0.6 0.01 
10 g, 60 g, and 120 g of ƐNALL (CJ Bio). 
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For experiment 2, we did not see any differences for DMI, milk yield, milk protein, or milk 
fat (Table 5). There was a trend (Table 6; P = 0.08) for cows treated with ƐNALL to have a 
higher rumen pH than cows treated with diNALL. The acetate to propionate ratio was greater 
(Table 6; p < 0.01) for ƐNALL than for the 0 g dose or diNALL. There were no differences 
seen in the blood LYS AUC (Table 6; P = 0.41). The diNALL product had blood LYS AUC 
that was numerically lower than the 0 g dose and the ƐNALL. This may indicate that the LYS 
was not being absorbed as well as had been anticipated. We also did not observe any significant 
differences between treatments for the percentage of LYS that escaped the rumen, duodenal 
AUC or duodenal appearance of NALL between the two forms (Table 7). 
 
 
Table 5. Dry matter intake, body weight, and milk parameters of second lactation dairy cows 
fed rumen protected lysine1 
 
 0 g ƐNALL diNALL SEM P 
DMI (kg/day) 37.7 38.9 37.1 3.28 0.61 
Milk Protein 3.21 3.21 3.26 0.091 0.51 
Milk Fat 3.75 3.73 3.68 0.252 0.74 
Lactose 4.15 4.07 4.13 0.208 0.35 
SNF 8.17 8.08 8.21 0.303 0.50 
SCC 240.1 267.8 266.1 51.51 0.57 
MUN 13.1 13.1 13.3 0.651 0.89 
Yield (kg/day) 15.45 15.27 16.01 0.868 0.65 
BW (kg) 786.7 786.5 586.5 113.41 0.46 
10 g, and 120 g ƐNALL (CJ Bio); 120 g diNALL (CJ Bio). 
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Table 6. Ruminal pH, ammonia-N, VFA profiles, and blood lysine AUC in second lactation 
dairy cows fed a diet with rumen-protected lysine1 
 0 g ƐNALL diNALL SEM P 
Rumen pH 6.23 6.31 6.18 0.120 0.08 
Duodenum pH 3.12 3.14 3.20 0.047 0.57 
NH3-N, mg/100 mL 5.89 4.69 5.45 0.604 0.28 
Individual VFA, mol/100 mol 
Acetate (A) 0.63 0.61 0.63 0.052 0.83 
Propionate (P) 0.20 0.19 0.21 0.027 0.29 
Butyrate 0.13 0.13 0.13 0.014 0.38 
Valerate 0.02 0.02 0.02 0.001 0.12 
Isobutyrate 0.01 0.01 0.01 0.001 0.51 
Isovalerate 0.02 0.02 0.02 0.002 0.19 
A:P 3.11 3.31 3.16 0.202 0.03 
Blood lysine      
Baseline 171.8 56.6 122.2 50.42 0.30 












10 g, and 120 g ƐNALL (CJ Bio); 120 g diNALL (CJ Bio). 
 
 
During experiment 1, the rumen escape for ƐNALL was 32.7% and 27.2 % for the 120 g 
and 60 g doses respectively (Table 4). Rumen escape was 44.2% for ƐNALL and 42.8% for 
diNALL during experiment 2 (Table 7). This is much greater than the expected 3% of free 
dietary LYS that reaches the small intestine (Robinson et al., 2006). A study by Amos and 
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Evans (1978) found that only 5% of L-Lysine-HCl bypassed the rumen. Watanabe et al. (2003) 
found that some LYS products provide as much as 75% rumen bypass, but the true amount that 
becomes available for absorption in the small intestine varies, and is often quite low. Further 
research is needed to determine the overall bioavailability of NALL. 
 
 
Table 7. Ruminal escape and duodenal appearance NALL in second lactation dairy cows fed a 
diet with rumen-protected lysine1 
 0 g ƐNALL diNALL SEM P 
Ruminal 
volume, L 
140.47 139.64 140.70 0.456 0.25 
Ruminal flow 
rate, L/h 
13.24 20.06 18.82 3.543 0.36 
Fractional rate 
constants, /h 
     
Liquid 0.14 0.09 0.13 0.025 0.32 
Ruminal 
NALL 
… 0.43 0.42 0.115 0.51 
Ruminal 
escape, % of 
dose 




… 153.6 175.0 25.0 0.36 
Duodenal NALL 
appearance, % of 
dose 
… 2.4 2.1 0.7 0.78 
10 g, and 120 g ƐNALL (CJ Bio); 120 g diNALL (CJ Bio). 
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The percentage of NALL that appeared in the duodenum was low for all of the treatments 
for experiment 1 (Table 4) and for experiment 2 (Table 7). According to Baxter et. al (2001), the 
low pH of the abomasum allows enzymes to split the acetyl group from the NALL. The low 
percentage of appearance may indicate that the acetyl group is being efficiently cleaved from the 
amino acid prior to duodenal collection. Further research could test this by testing for the 
presence of different end products in the small intestine.  Highly degradable NALL would 
supply more absorbable LYS in the small intestine. 
The increased overall VFA production for NALL seen in experiment 1 would mean better 
feed efficiency. However, these same effects were not seen in experiment 2. This may be due to 
increased DIM. Previous research by Stockdale et al., (1987) saw decreased VFA response to 
treatments as lactation progressed. A decrease in DMI may largely be responsible for the 
decreased response to treatments (Friggens et al, 1998). Further research would need to be 
undertaken to see if the effects on VFA could be recreated and utilized. Overall, NALL shows 
potential to provide rumen protection while allowing degradation into absorbable LYS in the 





The main focus of this study was to observe the ability of the NALM and NALL products to 
effectively protect MET and LYS in the rumen and still allow these AA to be released for 
absorption in the small intestine.  The NALM and NALL were fed along with a typical dairy 
diet to measure rumen protection and see effects of supplementation on milk production and 
DMI. It was expected that milk protein and milk yield would be affected by the rumen-protected 
MET and LYS. It was found that the acetylated MET and LYS were protected from rumen 
degradation but appeared to be changed post-ruminally. No negative effects on DMI were 
observed for either the NALM or the NALL. Adequate rumen protection of MET was observed 
for both treatments of the NALM. The 30 g had a higher percent escape than the 60 g dose. 
This indicates that the optimum dosage is closer to the 30 g than the 60 g dosage. Future studies 
are needed to determine where the optimum dosage is so that the benefits of supplementation can 
be maximized. The NALL product also protected LYS from degradation in the rumen. Neither 
NALL product appeared to be better than the other. Testing this dosage against other dosages to 
determine the optimum is also necessary for the NALL products. The NALM and both NALL 
products had low duodenal appearance.  It needs to be determined if this low appearance is due 
to the effective cleaving of the acetyl group from the AA. Future studies should test for the 
products of this cleavage to see if they are present in the duodenum. Although low duodenal 
appearance seems to indicate release of the AA, neither study observed significantly increased 
blood concentration of MET or LYS. However, neither of these studies were designed to 
specifically evaluate the absorption into the blood. The NALM product had numerically higher 
blood concentration of the AA for the lower dosages than the 0 g dose. The absorption of the 
57 
 
AA may have been inhibited if the dosages were too high. A high dose during the adaptation 
period may have caused a down-regulation of absorption pathways. During the first experiment 
with NALL, significantly increased VFA production was observed. Adequate rumen protection 
and intestinal availability combined with increased VFA production would be beneficial for 
dairy herds. Having more VFA availability increases the energy available for use by the cow. 
Overall, these studies indicate that NALM and NALL have potential to provide rumen 
protection. The effectiveness of releasing the AA in the small intestine requires further research. 
Determining the optimum dosages will help to increase the benefit of these products. There also 
appears to be potential to increase rumen fermentation products, which is important for 
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